Literature DB >> 7862527

Regulation of fibronectin expression in rat regenerating liver.

M Caputi1, C A Melo, F E Baralle.   

Abstract

Fibronectin (FN) expression displays a complex regulation that results in precisely defined isoform patterns during different developmental stages, ageing and injury. The qualitative and quantitative changes that are observed derive from modulation of the rate of transcription of the single FN pre-mRNA and its specific differential processing in the EIIIA, EIIIB and V regions of rat FN. The liver is the major source of plasma FN which is characterised by the absence of the EIIIA and EIIIB exons. Here we show that in the rat regenerating liver there is a significant reprogramming of the splicing machinery that results in the synthesis by the liver of up to 17% of EIIIA+ FN linked with all the three V forms. On the other hand the EIIIB+ form is totally absent both in normal and regenerating liver. Furthermore there is a variation of the V pattern observed in the regenerating tissue, the V120 form (linked to both EIIIA+ and EIIIA- messengers) increases from 11 to 32%. The quantitative RT-PCR method was used to estimate the FN transcription rate, before and after partial hepatectomy. We have shown a 3-fold increase in FN mRNA in liver that is specifically linked to the regeneration process and not to the surgical stress.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862527      PMCID: PMC306660          DOI: 10.1093/nar/23.2.238

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

Review 1.  Molecular biology of the extracellular matrix proteins.

Authors:  A R Kornblihtt; A Gutman
Journal:  Biol Rev Camb Philos Soc       Date:  1988-11

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 3.  Molecular biology of fibronectin.

Authors:  R Hynes
Journal:  Annu Rev Cell Biol       Date:  1985

4.  Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA.

Authors:  A Gutman; A R Kornblihtt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon.

Authors:  M Caputi; G Casari; S Guenzi; R Tagliabue; A Sidoli; C A Melo; F E Baralle
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

6.  Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells.

Authors:  P A Norton; R O Hynes
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

7.  Isolation and characterization of cDNA clones for human and bovine fibronectins.

Authors:  A R Kornblihtt; K Vibe-Pedersen; F E Baralle
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Organization of the fibronectin gene provides evidence for exon shuffling during evolution.

Authors:  R S Patel; E Odermatt; J E Schwarzbauer; R O Hynes
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

9.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.

Authors:  L Zardi; B Carnemolla; A Siri; T E Petersen; G Paolella; G Sebastio; F E Baralle
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

10.  Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines.

Authors:  D C Dean; R F Newby; S Bourgeois
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more
  9 in total

Review 1.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice.

Authors:  Kei Moriya; Keiko Sakai; Michel H Yan; Takao Sakai
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

3.  Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats.

Authors:  L P Lim; P A Sharp
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

4.  HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver.

Authors:  K Du; Y Peng; L E Greenbaum; B A Haber; R Taub
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing.

Authors:  S Kadener; P Cramer; G Nogués; D Cazalla; M de la Mata; J P Fededa; S E Werbajh; A Srebrow; A R Kornblihtt
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

Review 6.  New insights into form and function of fibronectin splice variants.

Authors:  E S White; F E Baralle; A F Muro
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

7.  Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy.

Authors:  Bridget Sackey-Aboagye; Abby L Olsen; Sarmistha M Mukherjee; Alexander Ventriglia; Yasuyuki Yokosaki; Linda E Greenbaum; Gi Yun Lee; Hani Naga; Rebecca G Wells
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

8.  Host microvasculature influence on tumor vascular morphology and endothelial gene expression.

Authors:  W G Roberts; J Delaat; M Nagane; S Huang; W K Cavenee; G E Palade
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon.

Authors:  Emanuele Buratti; Andrés F Muro; Maurizio Giombi; Daniel Gherbassi; Alessandra Iaconcig; Francisco E Baralle
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.